Huajian Medical has begun applying for a U.S. stablecoin license and plans to raise funds to increase its dollar reserves

华检医疗 (1931) announced the suspension of its planned cryptocurrency acquisition not exceeding 3 billion yuan, and will disclose Ethereum (ETH) transactions in accordance with listing rules in the future. At the same time, the acquisition of a 20.31% stake in Guofu Quantum (0290) for 3.142 billion yuan has been canceled.

The company has adjusted its strategy, starting to apply for a U.S. stablecoin license and plans to raise funds to increase its dollar reserves, while simultaneously developing an AI algorithm platform that integrates the distribution network with the RWA platform to enhance the accuracy of asset valuation models.